Teva Pharmaceutical Industries (TEVA) EBIT (QoQ) (2009 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EBIT (QoQ) (2009 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -135.43% |
| Mar 31, 2026 | 117.33% |
| Dec 31, 2025 | -65.99% |
| Sep 30, 2025 | 93.85% |
| Jun 30, 2025 | -12.33% |
| Mar 31, 2025 | 1,889.66% |
| Dec 31, 2024 | 43.14% |
| Sep 30, 2024 | -920.00% |
| Jun 30, 2024 | 97.71% |
| Mar 31, 2024 | -128.84% |
| Dec 31, 2023 | 119.77% |
| Sep 30, 2023 | 152.60% |
| Jun 30, 2023 | -4,930.77% |
| Mar 31, 2023 | 98.62% |
| Dec 31, 2022 | -321.70% |
| Sep 30, 2022 | 143.85% |
| Jun 30, 2022 | -35.62% |
| Mar 31, 2022 | -1,014.10% |
| Dec 31, 2021 | -87.48% |
| Sep 30, 2021 | 7.04% |